Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. - Wikidata - wikimedia - TriplyDB

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

http://www.wikidata.org/entity/Q34213437

about

Doubly robust estimation and causal inference in longitudinal studies with dropout and truncation by death.Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany Drug resistance profiles of Mycobacterium tuberculosis complex and factors associated with drug resistance in the Northwest and Southwest Regions of Cameroon Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors.A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa Incidence of tuberculosis and immunological profile of TB/HIV co-infected patients in Nigeria.Hierarchy Low CD4+/CD8+ T-Cell Counts and IFN-γ Responses in HIV-1+ Individuals Correlate with Active TB and/or M.tb Co-Infection Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death HIV and co-infections.Declining tuberculosis case notification rates with the scale-up of antiretroviral therapy in Zimbabwe Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles.High rates of tuberculosis in patients accessing HAART in rural South Africa.Antiretroviral Treatment Efficacy and Safety in Older HIV-Infected Adults.Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.Is systematic screening and treatment for latent tuberculosis infection in HIV patients useful in a low endemic setting?Timing of Antiretroviral Treatment, Immunovirologic Status, and TB Risk: Implications for Testing and Treatment.Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.Reversible severe encephalitis and word deafness following rapid immune reconstitution in AIDS: a case report.Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.Using Observational Data to Calibrate Simulation Models.Incidence and associated factors of pulmonary tuberculosis in HIV-infected children after highly active antiretroviral therapy (HAART) in China: a retrospective study

P2860

Q27304216-7039142C-6DE0-4AE3-94FA-FB4AFD5CC145 Q28387169-4DFCC20F-DAA9-4D65-81DC-18D41C31E746 Q28397652-7125AF0D-5802-453F-88FC-78906DA0AA9E Q28534467-AB50FD90-D557-4429-844B-3B3734C91834 Q33622785-98539429-2B76-44B8-927C-E11AC5CB5BC1 Q33707284-4BFAEF80-6CDF-4761-A7FA-4D1CE175E188 Q34387168-CE23F631-4761-4AA9-A2FC-F166286F1AF4 Q34999621-4B07676B-C4FE-4D53-91D2-A27F58E09C09 Q35124693-B3656650-3F93-4F68-84CB-E12190272338 Q35514622-5E3AC945-365C-423C-805E-16A8F5176344 Q35898590-72E22744-0838-4374-A30F-09E3E7582573 Q35950895-4B450A26-0133-4772-BDD8-8ADAB02A4D1A Q36956948-64DE5951-A804-4CE3-8BEF-C578CC938B2B Q36970184-E7E0641F-4DC9-4D2F-A292-975143B4191B Q37279224-73FBDDD8-2A78-4BA7-BD9A-558F2279B312 Q37461125-0FDC741D-64B4-468E-ACC6-FAB36C330B93 Q37519812-369008CC-DE56-4AED-A3FE-E59CAC7512BA Q37619616-11E9D561-99D8-434C-853B-A5617978A2A0 Q38673884-2E77F49D-2B76-4848-AD86-E65A28AA8128 Q40347065-95E4267C-D183-4D43-8378-BBA891AECE32 Q40522525-DAB7A3D6-E3B0-4217-9732-94023B5647E0 Q40726699-6E1A3F9A-2410-4F23-96BF-7FC1CEFFCC56 Q40867178-AC00778F-ECDC-4B09-A627-F99A9D40C5EF Q45999690-F1705068-6E2A-4A4D-B130-A92EB4B1E295 Q47547617-8FFAF0D0-0787-48D3-AD19-E273751474FD Q47592139-23B1C9B4-2409-45EB-8A50-737BC158B211 Q58305192-680885A7-EA8D-4B6F-AE8F-EB6947168DCF

P2860

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

http://www.wikidata.org/entity/Q34213437

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Impact of antiretroviral thera ...... ents in high-income countries.

@ast

Impact of antiretroviral thera ...... ents in high-income countries.

@en

Impact of antiretroviral thera ...... ents in high-income countries.

@nl

type

label

Impact of antiretroviral thera ...... ents in high-income countries.

@ast

Impact of antiretroviral thera ...... ents in high-income countries.

@en

Impact of antiretroviral thera ...... ents in high-income countries.

@nl

prefLabel

Impact of antiretroviral thera ...... ents in high-income countries.

@ast

Impact of antiretroviral thera ...... ents in high-income countries.

@en

Impact of antiretroviral thera ...... ents in high-income countries.

@nl

P1433

Q34213437-6F06106C-D8CB-400C-A440-DB9B98BEB56D

P1476

Q34213437-31717B63-EE3B-4609-9BFA-50ECF1E743BD

P2093

Q34213437-10DCEF31-98BC-43B9-9987-5ED59C19D657

Q34213437-15F12F42-AEC6-460E-B6EC-8B427FC11ED6

Q34213437-195EEC99-B8D7-4BFE-B853-3B1798327791

Q34213437-32F0A533-8202-4467-99B2-9EC64AED51D3

Q34213437-37B56A35-FD5E-47FC-B745-5AA4AD936191

Q34213437-559CA5CF-01C7-4047-AAF3-65EB710B6ABE

Q34213437-60FAEC04-62B3-4C91-A73F-1713490E7F7D

Q34213437-6194D467-A764-4A13-96D7-81AD0F7F1AC5

Q34213437-6F2DA58B-B117-4342-9CB9-6D5C1C777840

Q34213437-84F58454-47E9-43D0-B3FC-4425C3B0D0B1

P2860

Q34213437-093E9009-3E6C-488D-8126-86333E7CDF80

Q34213437-122CBE5B-F18B-4A67-AC8B-C67F0776FE18

Q34213437-12DA32D9-AF4F-412E-8DE5-DBBF80713F8D

Q34213437-155F489D-4F20-4037-B047-513699D171C5

Q34213437-330B5E82-A1C0-4844-9E0D-C3E0A1EF09A6

Q34213437-3DB49A5B-53A3-4FBE-BEAC-E06E770F7980

Q34213437-41FB5E58-DBD8-4A12-A84D-2DBD378FB5C8

Q34213437-4A99AE87-F7AC-47BE-BDFD-E2D45F6D67F9

Q34213437-5032B71D-6A77-46C0-95A2-471615C4877D

Q34213437-5DAF7031-C950-4344-9B87-F0EE96F1D579

P304

Q34213437-43DAD6D9-1821-4671-A255-FEDF03C4C041

P31

Q34213437-FFD39EC0-A3AA-4637-A4A7-4D2A4CDC658C

P356

Q34213437-946D71F8-79C6-4BB4-99AD-F337C2C12E6D

P407

Q34213437-EBE09B3B-24EE-45A8-98D0-0F1438F5FE83

P433

Q34213437-5F6ACFCC-3DBF-4DC9-A1A8-A1A2E71CD847

P478

Q34213437-8E31D5A4-52C9-4D01-9758-E283CA6BE28D

P50

Q34213437-0D3BBE49-272C-49F8-B8EB-59C5B89FADFA

Q34213437-72A70457-F433-4B81-AD7E-B700F705F6E7

Q34213437-E1EE9654-16DF-4C7E-AE46-71D6152718D0

Q34213437-E80AB8FB-59AB-4AE9-B698-1BD31136F611

Q34213437-FD002BC7-7AD8-4F5A-BF08-E17D68BC2ACC

P577

Q34213437-5FBAB512-FEB9-4AA3-8846-03C1024DBFC7

P5875

Q34213437-E0155084-7765-4D37-A93C-01B6EFB9C991

P698

Q34213437-0AA3A185-1DC9-4480-9CBD-88D398F4A7FF

P921

Q34213437-2BAB0576-C91B-4CD0-AD27-A0097A5B84B9

Q34213437-3920F821-5118-4BDD-A4DA-3EEE5769881A

P932

Q34213437-E751630E-73E6-46C8-90C7-2B0ABCA59CD0

P356

P1433

Clinical Infectious Diseases

P1476

Impact of antiretroviral thera ...... ents in high-income countries.

@en

P2093

Amy Justice

http://www.w3.org/2001/XMLSchema#string

Andrew Phillips

http://www.w3.org/2001/XMLSchema#string

Elena Ferrer

http://www.w3.org/2001/XMLSchema#string

Giota Toulomi

http://www.w3.org/2001/XMLSchema#string

HIV-CAUSAL Collaboration

http://www.w3.org/2001/XMLSchema#string

Heiner C Bucher

http://www.w3.org/2001/XMLSchema#string

Inma Jarrín

http://www.w3.org/2001/XMLSchema#string

Joseph Goulet

http://www.w3.org/2001/XMLSchema#string

José M Miró

http://www.w3.org/2001/XMLSchema#string

Julia del Amo

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

Marginal structural models and causal inference in epidemiology

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

A structural approach to selection bias.

Changing concepts of "latent tuberculosis infection" in patients living with HIV infection.

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.

Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.

P304

1364-1372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIS203

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Hansjakob Furrer

Dominique Costagliola

Jonathan Sterne

P577

2012-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232804528

http://www.w3.org/2001/XMLSchema#string

P698

22460971

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

antiretroviral drug

P932

3404691

http://www.w3.org/2001/XMLSchema#string